JPRN-UMIN000005295
Recruiting
Phase 2
Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy - Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy
Department of Gastroenterological Surgery,Graduate School of medicine,Osaka University0 sites25 target enrollmentMarch 23, 2011
Conditionsesophageal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- esophageal cancer
- Sponsor
- Department of Gastroenterological Surgery,Graduate School of medicine,Osaka University
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •patients with serous concomitant diseas patients with serious infectiou disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study - radiotherapy for vulvar canceradvanced stage squamous cell cancer of the vulvaMedDRA version: 8.1Level: LLTClassification code 10047777Term: Vulvar cancerEUCTR2006-004052-20-NLKoningin Wilhelmina Fonds
Completed
Phase 2
Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy studyvulvar cancervulvar neoplasm1003859710029903NL-OMON30199Academisch Medisch Centrum68
Active, Not Recruiting
Phase 2
Phase II study of definitive chemoradiotherapy with S-1 plus cisplatin for clinical stage IA esophageal squamous cell carcinoma. (SP-RT)JPRN-jRCTs051180078Yamamoto Sachiko76
Completed
Phase 2
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)locally advanced esophageal carcinomaJPRN-UMIN000002029Kitasato University School of Medicine35
Not Yet Recruiting
Phase 1
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24